德英生物科技
Inquiry Cart

Important resolutions of the Board of Directors in 2023

Important Resolutions of the Board of Directors in 2023 (Year 112)

▌Note: The table can be scrolled horizontally
Date Main Agenda Resolution
2023.03.10 Agenda 1: The Company’s 2022 Financial Statements submitted for review. With no objection from all attending directors, the proposal was approved. After accountants 田中玉 and 林永智 of PwC Taiwan complete the audit and certification of the 2022 financial statements, the case will be submitted to the shareholders’ meeting for approval.
Agenda 2: The Company’s 2022 Business Report and Statement of Profit and Loss Appropriation submitted for discussion. The proposal was approved with consent from all attending directors and will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 3: Allocation of Statutory Earnings Reserve and Capital Surplus to offset accumulated losses submitted for discussion. The proposal was approved with consent from all attending directors and will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 4: Completion of the Company’s 2022 Internal Control Self-Assessment and issuance of the Internal Control System Statement submitted for discussion. The proposal was approved with no objections.
Agenda 5: Appointment of the Company’s Corporate Governance Officer submitted for discussion. The personnel appointment was approved with consent from all attending directors.
Agenda 6: Evaluation report on the suitability of the Company’s CPAs submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 7: Independence assessment of the Company’s certifying CPAs submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 8: Appointment of PwC Taiwan CPAs 田中玉 and 葉芳婷 as auditors for the Company’s 2023 financial report submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 9: Pre-approval for CPAs, their firms, and related entities to provide non-assurance services to the Company submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 10: Engagement of PwC Taiwan to conduct the 2023 financial statement audit, corporate income tax filing, and submission of full-time non-managerial salary information submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 11: Amendments to the Company’s “Insider Trading Prevention Procedures” submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 12: Recognition of incentives paid to employees (including managerial staff) for 2022 submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 13: Arrangements for convening the 2023 Annual Shareholders’ Meeting submitted for discussion. The proposal was approved with consent from all attending directors.
2023.05.05 Agenda 1: The Company’s Q1 2023 Financial Report submitted for review. The proposal was approved with no objections from attending directors.
Agenda 2: Renewal of Directors’ Liability Insurance for 2023 submitted for discussion. The proposal was approved with no objections from attending directors.
Agenda 3: Mid-year performance bonus distribution for employees (including managerial staff) in 2023 submitted for discussion. Approved with authorization granted to the General Manager to distribute bonuses based on employees’ daily work performance and contributions.
2023.08.04 Agenda 1: Proposal to change the Company’s certifying CPA starting Q2 2023 submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 2: The Company’s Q2 2023 Financial Report submitted for review. The proposal was approved with consent from all attending directors.
Agenda 3: Amendments to the Company’s “Rules of Procedure for Shareholders’ Meetings” submitted for discussion. The proposal was approved and will be included in the agenda of the upcoming Annual Shareholders’ Meeting.
Agenda 4: Procurement of one spray dryer to meet operational needs submitted for discussion. The procurement proposal was approved with consent from all attending directors.
2023.11.03 Agenda 1: The Company’s Q3 2023 Financial Report submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 2: Appointment of the Company’s Chief Information Security Officer submitted for discussion. After review by attending independent directors, the appointment was approved.
Agenda 3: Amendments to the Internal Control System – “IT Cycles: Functions and Responsibilities” submitted for discussion. The proposal was approved with consent from all attending directors.
2023.12.05 Agenda 1: Establishment of the Company’s 2024 Budget submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 2: Establishment of the Company’s 2024 Audit Plan submitted for discussion. The proposal was approved with consent from all attending directors.
Agenda 3: Mid-year performance bonus distribution for employees (including managerial staff) for 2023 submitted for discussion. The proposal was approved with authorization granted to the General Manager to distribute bonuses based on employees’ actual daily performance and contributions.